Hematopoietic Cell Transplantation after CD19 Chimeric Antigen Receptor T Cell-Induced Acute Lymphoblastic Leukemia Remission Confers a Leukemia-Free Survival AdvantageCorinne Summers, Rebecca Gardner, Qian Wu et al.|Transplantation and Cellular Therapy|2021Cited by 64
Efficacy of SCRI-CAR19x22 T cell product in B-ALL and persistence of anti-CD22 activity.Rebecca Gardner, Michael C. Jensen, Vicky Wu et al.|Journal of Clinical Oncology|2020Cited by 13
ENLIGHten-01: A phase 1 study of fluorescein-specific (FITC-E2)-CAR T cells in combination with folate-fluorescein (UB-TT170) for osteosarcoma.Catherine M. Albert, Julie R. Park, Navin Pinto et al.|Journal of Clinical Oncology|2023Cited by 6
IMMU-01. PIONEERING QUAD-TARGETING CAR T CELL THERAPY IN PEDIATRIC CNS TUMORS – ANALYSIS FROM THE INITIAL PATIENTS TREATED ON THE FIRST-IN-HUMAN PHASE 1 TRIAL BRAINCHILD-04Rebecca Ronsley, Nicholas A. Vitanza, Michelle Choe et al.|Neuro-Oncology|2024Cited by 3
CTIM-02. PIONEERING QUAD-TARGETING CAR T CELL THERAPY IN PEDIATRIC CNS TUMORS – ANALYSIS FROM THE INITIAL PATIENTS TREATED ON THE FIRST-IN-HUMAN PHASE 1 TRIAL BRAINCHILD-04Rebecca Ronsley, Nicholas A. Vitanza, Kristy Seidel et al.|Neuro-Oncology|2024Cited by 2